Clinical Decision Making in the Management of Breast Cancer Diagnosed During Pregnancy: A Review and Case Series Analysis

2021 ◽  
Author(s):  
Nadom Safi ◽  
Christobel Saunders ◽  
Antoinette Anazodo ◽  
Jan E. Dickinson ◽  
Frances Boyle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Clinical Decision Making ◽  
Case Series ◽  
Clinical Decision ◽  
Series Analysis

scholarly journals Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer

2014 ◽  
Vol 110 (7) ◽  
pp. 1688-1697 ◽  
Author(s):  
E A Rakha ◽  
D Soria ◽  
A R Green ◽  
C Lemetre ◽  
D G Powe ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Clinical Decision Making ◽  
Prognostic Index ◽  
Clinical Decision ◽  
Nottingham Prognostic Index ◽  
Decision Making Tool

scholarly journals Analysing Breast Cancer Multidisciplinary Patient Management: A Prospective Observational Evaluation of Team Clinical Decision-Making

2018 ◽  
Vol 43 (2) ◽  
pp. 559-566 ◽  
Author(s):  
T. A. K. Gandamihardja ◽  
T. Soukup ◽  
S. McInerney ◽  
J. S. A. Green ◽  
N. Sevdalis
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Patient Management ◽  
Clinical Decision Making ◽  
Clinical Decision

scholarly journals Influence of breast reconstruction on technical aspects of echocardiographic image acquisition compared with physician-assessed image quality

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Joaquin Duarte Ow ◽  
Mohamad Hemu ◽  
Anel Yakupovich ◽  
Parva Bhatt ◽  
Hannah Gaddam ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Image Quality ◽  
Cardiac Function ◽  
Breast Reconstruction ◽  
Clinical Decision Making ◽  
Image Acquisition ◽  
Clinical Decision ◽  
Echocardiographic Image ◽  
Significant Difference

Abstract Introduction Assessment of cardiac function after treatment for breast cancer relies on interval evaluation of ventricular function through echocardiography. Women who undergo mastectomy more frequently choose to undergo breast reconstruction with implant. This could impede assessment of cardiac function in those with left-sided implant. We aimed to examine whether left-sided breast reconstruction with tissue expanders (TE) affect echo image acquisition and quality, possibly affecting clinical decision-making. Methods A retrospective case-control study was conducted in 190 female breast cancer patients who had undergone breast reconstruction with TE at an urban academic center. Echocardiographic technical assessment and image quality were respectively classified as excellent/good or adequate/technically difficult by technicians; and excellent/good or adequate/poor by 2 board-certified cardiologist readers. Likelihood ratio was used to test multivariate associations between image quality and left-sided TE. Results We identified 32 women (81.3% white; mean age 48 years) with left-sided/bilateral TE, and 158 right-sided/no TE (76.6% white, mean age 57 years). In multivariable analyses, we found a statistically significant difference in technician-assessed difficulty in image acquisition between cases and controls (p = 0.01); but no differences in physician-assessed image quality between cases and controls (p = 0.09, Pearson’s r = 0.467). Conclusions Left-sided breast TE appears to affect the technical difficulty of echo image acquisition, but not physician-assessed echo image quality. This likely means that echo technicians absorb most of the impediments associated with imaging patients with breast TE such that the presence of TE has no bearing on downstream clinical decision-making associated with echo image quality.

Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making — A Selected Case Series

2018 ◽  
Vol 230 (06) ◽  
pp. 305-313 ◽  
Author(s):  
Heidi Bächli ◽  
Jonas Ecker ◽  
Cornelis van Tilburg ◽  
Dominik Sturm ◽  
Florian Selt ◽  
...  
Keyword(s):  
Decision Making ◽  
Molecular Diagnostics ◽  
Clinical Management ◽  
Clinical Decision Making ◽  
Case Series ◽  
Clinical Decision ◽  
Cns Tumors ◽  
Molecular Testing ◽  
Cancer Predisposition Syndrome ◽  
Pediatric Cns Tumors

AbstractCentral nervous system (CNS) tumors account for the highest mortality among pediatric malignancies. Accurate diagnosis is essential for optimal clinical management. The increasing use of molecular diagnostics has opened up novel possibilities for more precise classification of CNS tumors. We here report a single-institutional collection of pediatric CNS tumor cases that underwent a refinement or a change of diagnosis after completion of molecular analysis that affected clinical decision-making including the application of molecularly informed targeted therapies. 13 pediatric CNS tumors were analyzed by conventional histology, immunohistochemistry, and molecular diagnostics including DNA methylation profiling in 12 cases, DNA sequencing in 8 cases and RNA sequencing in 3 cases. 3 tumors had a refinement of diagnosis upon molecular testing, and 6 tumors underwent a change of diagnosis. Targeted therapy was initiated in 5 cases. An underlying cancer predisposition syndrome was detected in 5 cases. Although this case series, retrospective and not population based, has its limitations, insight can be gained regarding precision of diagnosis and clinical management of the patients in selected cases. Accuracy of diagnosis was improved in the cases presented here by the addition of molecular diagnostics, impacting clinical management of affected patients, both in the first-line as well as in the follow-up setting. This additional information may support the clinical decision making in the treatment of challenging pediatric CNS tumors. Prospective testing of the clinical value of molecular diagnostics is currently underway.

Sign in / Sign up

Export Citation Format

Share Document